Tech Company Financing Transactions
FluGen Funding Round
On 3/31/2016, FluGen announced $3.4 million in financing from private investors and Venture Investors.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$3,388,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
597 Science Dr.
Madison, WI 53711
USA
Madison, WI 53711
USA
Phone
Website
Email Address
Overview
FluGen is driving the development of a universal flu vaccine to advance human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Radspinner
Chief Scientific Officer
Pamuk Bilsel
VP - R & D
Renee Herber
Browse more venture capital transactions:
Prev: 3/31/2016: PanOptica venture capital transaction
Next: 3/31/2016: Brideside venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs